- On sale!
- -11%
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
TriTren 150 is Dragon Pharma's pre-combined triple-ester Trenbolone blend at 150mg/ml β combining Trenbolone Acetate, Trenbolone Hexahydrobenzylcarbonate (Parabolan) and Trenbolone Enanthate in a single injection. Each ester releases at a different rate, producing a phased hormonal curve: an early peak from the Acetate component, a sustained mid-term level from the Enanthate, and a prolonged baseline from the Hexahydrobenzylcarbonate.
Also searched as: TriTren 150mg, Tren blend mix, Trenbolone tri-ester, TriTren Dragon Pharma.
The rationale for combining three Trenbolone esters mirrors the logic behind multi-ester testosterone blends like Sustanon, but with a compound where the ester choice carries greater practical consequences:
| Component | Approx. Amount | Half-Life | Role in Blend |
|---|---|---|---|
| Trenbolone Acetate | ~50 mg/ml | ~2β3 days | Fast-onset component β blood levels rise rapidly after injection |
| Trenbolone Hexahydrobenzylcarbonate | ~50 mg/ml | ~14 days | Long-baseline component β maintains a prolonged hormonal floor |
| Trenbolone Enanthate | ~50 mg/ml | ~7β10 days | Mid-range component β bridges fast and slow ester release curves |
The combined effect: after a TriTren injection, the Acetate component begins releasing within hours, reaching peak contribution within 1-2 days. The Enanthate component builds over 3-5 days. The Hexahydrobenzylcarbonate component extends the hormonal curve beyond both, maintaining Trenbolone activity for up to 3+ weeks from a single injection. Unlike single-ester products where blood levels follow a predictable single-peak curve, TriTren produces a broader, more sustained hormonal profile.
| Parameter | TriTren 150 | Tren Acetate (single) | Tren Enanthate (single) |
|---|---|---|---|
| Onset speed | Fast β Acetate component active within hours | Fast | Slow β days to meaningful levels |
| Blood level stability | Broad plateau β 3 overlapping release curves | More variable β shorter half-life peaks | Stable β single long-ester curve |
| Side effect predictability | Complex β multiple overlapping pharmacokinetics | Most predictable | Predictable |
| Injection frequency | 2β3Γ weekly | EOD | 2Γ weekly |
| PCT timing | 3β4 weeks post β driven by longest ester (Hex) | 5β7 days post | 14β21 days post |
| Best for | Experienced users wanting fast onset + sustained levels in one vial | First Tren cycle or fast-control protocols | Twice-weekly convenience |
| Experience Level | Weekly Dose | Frequency | Cycle Length |
|---|---|---|---|
| Intermediate (established Tren tolerance) | 300β450 mg/week | 2β3Γ weekly | 10β14 weeks |
| Advanced | 450β600 mg/week | 3Γ weekly | 10β14 weeks |
TriTren is not a beginner compound β the complex multi-ester pharmacokinetics make side effect management less straightforward than with single-ester Trenbolone products, and the presence of the long Hexahydrobenzylcarbonate ester means PCT cannot begin for 3-4 weeks after the last injection regardless of the shorter esters' clearance. Twice or three-times-weekly injections maintain the most stable blood levels from the combined release profile.